BiomX Inc.
PHGE
$0.5501
$0.00330.60%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 38.05% | 47.02% | 45.62% | 24.57% | 6.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.26% | 44.49% | 36.80% | 22.62% | 17.68% |
| Operating Income | -19.26% | -44.49% | -36.80% | -22.62% | -17.68% |
| Income Before Tax | 29.25% | 78.31% | 32.25% | 67.20% | -3.38% |
| Income Tax Expenses | -68.42% | -59.09% | -43.48% | -81.97% | -68.85% |
| Earnings from Continuing Operations | 29.28% | 78.30% | 32.26% | 67.23% | -3.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.28% | 78.30% | 32.26% | 67.23% | -3.20% |
| EBIT | -19.26% | -44.49% | -36.80% | -22.62% | -17.68% |
| EBITDA | -17.13% | -42.26% | -34.31% | -22.70% | -20.12% |
| EPS Basic | 76.45% | 87.99% | 52.77% | 58.81% | 42.47% |
| Normalized Basic EPS | 94.45% | 110.13% | 68.49% | 64.99% | 43.40% |
| EPS Diluted | 78.47% | 71.84% | 35.93% | 46.07% | 31.37% |
| Normalized Diluted EPS | 94.73% | 106.35% | 64.23% | 61.41% | 40.28% |
| Average Basic Shares Outstanding | 251.25% | 175.08% | 133.28% | 104.61% | 76.54% |
| Average Diluted Shares Outstanding | 205.78% | 191.11% | 151.67% | 126.24% | 102.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |